102 related articles for article (PubMed ID: 15686838)
1. Intermedilysin release by Streptococcus intermedius: effects of various antibacterial drugs at sub-MIC levels.
Taylor MB; Oh JH; Kang KL; Chow VT
FEMS Microbiol Lett; 2005 Feb; 243(2):379-84. PubMed ID: 15686838
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility of periodontal Streptococcus constellatus and Streptococcus intermedius clinical isolates.
Rams TE; Feik D; Mortensen JE; Degener JE; van Winkelhoff AJ
J Periodontol; 2014 Dec; 85(12):1792-8. PubMed ID: 25102269
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibitory effects of Polygonum cuspidatum on bacterial viability and virulence factors of Streptococcus mutans and Streptococcus sobrinus.
Song JH; Kim SK; Chang KW; Han SK; Yi HK; Jeon JG
Arch Oral Biol; 2006 Dec; 51(12):1131-40. PubMed ID: 16914113
[TBL] [Abstract][Full Text] [Related]
4. Influence of clindamycin on the stability of coa and fnbB transcripts and adherence properties of Staphylococcus aureus Newman.
Blickwede M; Wolz C; Valentin-Weigand P; Schwarz S
FEMS Microbiol Lett; 2005 Nov; 252(1):73-8. PubMed ID: 16165330
[TBL] [Abstract][Full Text] [Related]
5. Release of SpeA from Streptococcus pyogenes after exposure to penicillin: dependency on dose and inhibition by clindamycin.
Goscinski G; Tano E; Thulin P; Norrby-Teglund A; Sjölin J
Scand J Infect Dis; 2006; 38(11-12):983-7. PubMed ID: 17148065
[TBL] [Abstract][Full Text] [Related]
6. Positive- and Negative-Control Pathways by Blood Components for Intermedilysin Production in Streptococcus intermedius.
Tomoyasu T; Yamasaki T; Chiba S; Kusaka S; Tabata A; Whiley RA; Nagamune H
Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28607101
[No Abstract] [Full Text] [Related]
7. LuxS and expression of virulence factors in Streptococcus intermedius.
Pecharki D; Petersen FC; Scheie AA
Oral Microbiol Immunol; 2008 Feb; 23(1):79-83. PubMed ID: 18173802
[TBL] [Abstract][Full Text] [Related]
8. Induction of pro-inflammatory cytokine release by human macrophages during exposure of Streptococcus pneumoniae to penicillin is influenced by minimum inhibitory concentration ratio.
Moore LJ; Pridmore AC; Lee ME; Read RC
Int J Antimicrob Agents; 2005 Sep; 26(3):188-96. PubMed ID: 16099623
[TBL] [Abstract][Full Text] [Related]
9. Effect of sub-inhibitory concentrations of antibiotics on adhesion of Campylobacter jejuni in vitro.
Cinco M; Banfi E; Crevatin D; Ruaro E
Boll Ist Sieroter Milan; 1987; 66(2):106-9. PubMed ID: 3663336
[TBL] [Abstract][Full Text] [Related]
10. Effect of antibiotic sub inhibitory concentration on cytolethal distending toxin production by Campylobacter jejuni.
Ismaeel AY; Senok AC; Bindayna KM; Bakhiet M; Al Mahmeed A; Yousif AQ; Botta GA
J Infect; 2005 Aug; 51(2):144-9. PubMed ID: 16038766
[TBL] [Abstract][Full Text] [Related]
11. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain.
Dumitrescu O; Badiou C; Bes M; Reverdy ME; Vandenesch F; Etienne J; Lina G
Clin Microbiol Infect; 2008 Apr; 14(4):384-8. PubMed ID: 18261123
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and preliminary X-ray analysis of the human-specific toxin intermedilysin.
Polekhina G; Giddings KS; Tweten RK; Parker MW
Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):347-9. PubMed ID: 14747721
[TBL] [Abstract][Full Text] [Related]
13. Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro.
Spreer A; von Ruden C; Mitchell TJ; Eiffert H; Nau R
Chemotherapy; 2007; 53(5):327-31. PubMed ID: 17728540
[TBL] [Abstract][Full Text] [Related]
14. The human-specific action of intermedilysin, a homolog of streptolysin O, is dictated by domain 4 of the protein.
Nagamune H; Ohkura K; Sukeno A; Cowan G; Mitchell TJ; Ito W; Ohnishi O; Hattori K; Yamato M; Hirota K; Miyake Y; Maeda T; Kourai H
Microbiol Immunol; 2004; 48(9):677-92. PubMed ID: 15383705
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of clindamycin on Lactobacillus in vitro.
Aroutcheva A; Simoes JA; Shott S; Faro S
Infect Dis Obstet Gynecol; 2001; 9(4):239-44. PubMed ID: 11916182
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC
J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241
[TBL] [Abstract][Full Text] [Related]
17. The effects of subminimal inhibitory concentrations of beta-lactam antibiotics against Clostridium perfringens.
Kondo F; Kuroki H
Microbios; 2001; 105(412):163-74. PubMed ID: 11414501
[TBL] [Abstract][Full Text] [Related]
18. Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius.
Macey MG; Whiley RA; Miller L; Nagamune H
Infect Immun; 2001 Oct; 69(10):6102-9. PubMed ID: 11553548
[TBL] [Abstract][Full Text] [Related]
19. Role of catabolite control protein A in the regulation of intermedilysin production by Streptococcus intermedius.
Tomoyasu T; Tabata A; Hiroshima R; Imaki H; Masuda S; Whiley RA; Aduse-Opoku J; Kikuchi K; Hiramatsu K; Nagamune H
Infect Immun; 2010 Sep; 78(9):4012-21. PubMed ID: 20624907
[TBL] [Abstract][Full Text] [Related]
20. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess.
Nagamune H; Ohnishi C; Katsuura A; Fushitani K; Whiley RA; Tsuji A; Matsuda Y
Infect Immun; 1996 Aug; 64(8):3093-100. PubMed ID: 8757839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
